Advances in Understanding Benzene Health Effects and Susceptibility

被引:282
作者
Smith, Martyn T. [1 ]
机构
[1] Univ Calif Berkeley, Sch Publ Hlth, Div Environm Hlth, Superfund Res Program, Berkeley, CA 94720 USA
来源
ANNUAL REVIEW OF PUBLIC HEALTH, VOL 31 | 2010年 / 31卷
关键词
leukemia; hematology; molecular epidemiology; genetic polymorphism; risk assessment; ARYL-HYDROCARBON RECEPTOR; DNA TOPOISOMERASE-II; THERAPY-RELATED MYELODYSPLASIA; NON-HODGKIN-LYMPHOMA; MYELOID-LEUKEMIA; EXPOSED WORKERS; LYMPHOHEMATOPOIETIC MALIGNANCIES; OCCUPATIONAL-EXPOSURE; MONOCLONAL GAMMOPATHY; POTENTIAL MECHANISM;
D O I
10.1146/annurev.publhealth.012809.103646
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Benzene is a ubiquitous chemical in our environment that causes acute leukemia and probably other hematological cancers. Evidence for an association with childhood leukemia is growing. Exposure to benzene can lead to multiple alterations that contribute to the leukemogenic process, indicating a multimodal mechanism of action. Research is needed to elucidate the different roles of multiple metabolites in benzene toxicity and the pathways that lead to their formation. Studies to date have identified a number of polymorphisms in candidate genes that confer susceptibility to benzene hematotoxicity. However, a genome-wide study is needed to truly assess the role of genetic variation in susceptibility. Benzene affects the blood-forming system at low levels of occupational exposure, and there is no evidence of a threshold. There is probably no safe level of exposure to benzene, and all exposures constitute some risk in a linear, if not supralinear, and additive fashion.
引用
收藏
页码:133 / 148
页数:16
相关论文
共 132 条
  • [1] HEMATOTOXICITY AND CARCINOGENICITY OF BENZENE
    AKSOY, M
    [J]. ENVIRONMENTAL HEALTH PERSPECTIVES, 1989, 82 : 193 - 197
  • [2] AKSOY M, 1972, BRIT J IND MED, V29, P56
  • [3] AKSOY M, 1971, BRIT J IND MED, V28, P296
  • [4] The use of non-tumor data in cancer risk assessment: reflections on butadiene, vinyl chloride, and benzene
    Albertini, R
    Clewell, H
    Himmelstein, MW
    Morinello, E
    Olin, S
    Preston, J
    Scarano, L
    Smith, MT
    Swenberg, J
    Tice, R
    Travis, C
    [J]. REGULATORY TOXICOLOGY AND PHARMACOLOGY, 2003, 37 (01) : 105 - 132
  • [5] [Anonymous], [No title captured]
  • [6] BADHAM HJ, 2009, TOXICOL SCI IN PRESS
  • [7] Benzene metabolites antagonize etoposide-stabilized cleavable complexes of DNA topoisomerase IIα
    Baker, RK
    Kurz, EU
    Pyatt, DW
    Irons, RD
    Kroll, DJ
    [J]. BLOOD, 2001, 98 (03) : 830 - 833
  • [8] BIOLOGICAL MARKERS OF EXPOSURE TO BENZENE - S-PHENYLCYSTEINE IN ALBUMIN
    BECHTOLD, WE
    WILLIS, JK
    SUN, JD
    GRIFFITH, WC
    REDDY, TV
    [J]. CARCINOGENESIS, 1992, 13 (07) : 1217 - 1220
  • [9] Beelte S, 2008, MED KLIN, V103, P553, DOI 10.1007/s00063-008-1090-3
  • [10] Beelte S, 2009, MED KLIN, V104, P197, DOI 10.1007/s00063-009-1032-8